Related Experiment Video
Updated: Nov 21, 2025
Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Alcoholic Liver Disease and COVID-19 Pneumonia: A Case Series
Devika Kapuria1, Shubhra Upadhyay2, Rahul Shekhar2
1Department of Gastroenterology, University of New Mexico Health Science Center, Albuquerque, NM, USA.
Insights
COVID-19 poses risks for patients with alcoholic cirrhosis, a common condition in New Mexico. This study examines three such cases, highlighting the severe outcomes of coronavirus disease 2019 in this vulnerable population.
Area of Science:
- Hepatology
- Infectious Diseases
- Internal Medicine
Background:
- The novel coronavirus 2019 (COVID-19) pandemic has caused significant global morbidity and mortality.
- Gastrointestinal symptoms and elevated liver chemistries are frequent in COVID-19 patients.
- Pre-existing liver disease is associated with a high mortality rate (39.8%) in COVID-19 patients.
Abstract:
The novel coronavirus 2019 (COVID-19) was reported by the World Health Organization in December 2019, and since then it has progressed into a worldwide pandemic, causing significant morbidity and mortality. Gastrointestinal symptoms of COVID-19 and elevated liver chemistries are seen in up to 50% of infected patients. Recent reports have suggested a high mortality rate for COVID-19 in patients with pre-existing liver disease, having an associated mortality of 39.8%. Alcoholic liver disease is a significant cause of morbidity and mortality in New Mexico (USA), and we report here the clinical course and characteristics of three cases of patients with alcoholic cirrhosis who were admitted to our hospital with COVID-19.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...